AU2003267751A1 - Use of epothilone derivatives for the treatment of hyperparathyroidism - Google Patents
Use of epothilone derivatives for the treatment of hyperparathyroidismInfo
- Publication number
- AU2003267751A1 AU2003267751A1 AU2003267751A AU2003267751A AU2003267751A1 AU 2003267751 A1 AU2003267751 A1 AU 2003267751A1 AU 2003267751 A AU2003267751 A AU 2003267751A AU 2003267751 A AU2003267751 A AU 2003267751A AU 2003267751 A1 AU2003267751 A1 AU 2003267751A1
- Authority
- AU
- Australia
- Prior art keywords
- hyperparathyroidism
- treatment
- epothilone derivatives
- animal
- epothilone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000002980 Hyperparathyroidism Diseases 0.000 title abstract 2
- 150000003883 epothilone derivatives Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41859202P | 2002-10-15 | 2002-10-15 | |
| US60/418,592 | 2002-10-15 | ||
| PCT/IB2003/004514 WO2004035050A1 (en) | 2002-10-15 | 2003-10-13 | Use of epothilone derivatives for the treatment of hyperparathyroidism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003267751A1 true AU2003267751A1 (en) | 2004-05-04 |
Family
ID=32107949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003267751A Abandoned AU2003267751A1 (en) | 2002-10-15 | 2003-10-13 | Use of epothilone derivatives for the treatment of hyperparathyroidism |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060142354A1 (https=) |
| EP (1) | EP1553938B1 (https=) |
| JP (1) | JP4672368B2 (https=) |
| CN (1) | CN1297269C (https=) |
| AT (1) | ATE350034T1 (https=) |
| AU (1) | AU2003267751A1 (https=) |
| BR (1) | BR0315293A (https=) |
| CA (1) | CA2501717C (https=) |
| CY (1) | CY1106385T1 (https=) |
| DE (1) | DE60310975T2 (https=) |
| DK (1) | DK1553938T3 (https=) |
| ES (1) | ES2279139T3 (https=) |
| PT (1) | PT1553938E (https=) |
| SI (1) | SI1553938T1 (https=) |
| WO (1) | WO2004035050A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60330407D1 (de) | 2002-08-23 | 2010-01-14 | Sloan Kettering Inst Cancer | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1155689B1 (en) * | 1993-07-19 | 2006-09-20 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic stents and methods of their preparation |
| DK1367057T3 (da) * | 1996-11-18 | 2009-01-19 | Biotechnolog Forschung Gmbh | Epothiloner E og F |
| US6380394B1 (en) * | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| SK287775B6 (sk) * | 1998-02-05 | 2011-09-05 | Novartis Ag | Farmaceutická formulácia obsahujúca epothilon, infúzny roztok a použitie farmaceutickej formulácie |
| US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
-
2003
- 2003-10-13 CA CA2501717A patent/CA2501717C/en not_active Expired - Fee Related
- 2003-10-13 BR BR0315293-6A patent/BR0315293A/pt not_active IP Right Cessation
- 2003-10-13 SI SI200330741T patent/SI1553938T1/sl unknown
- 2003-10-13 PT PT03748446T patent/PT1553938E/pt unknown
- 2003-10-13 US US10/530,855 patent/US20060142354A1/en not_active Abandoned
- 2003-10-13 ES ES03748446T patent/ES2279139T3/es not_active Expired - Lifetime
- 2003-10-13 EP EP03748446A patent/EP1553938B1/en not_active Expired - Lifetime
- 2003-10-13 CN CNB200380101281XA patent/CN1297269C/zh not_active Expired - Fee Related
- 2003-10-13 AU AU2003267751A patent/AU2003267751A1/en not_active Abandoned
- 2003-10-13 JP JP2004544592A patent/JP4672368B2/ja not_active Expired - Fee Related
- 2003-10-13 WO PCT/IB2003/004514 patent/WO2004035050A1/en not_active Ceased
- 2003-10-13 AT AT03748446T patent/ATE350034T1/de active
- 2003-10-13 DK DK03748446T patent/DK1553938T3/da active
- 2003-10-13 DE DE60310975T patent/DE60310975T2/de not_active Expired - Lifetime
-
2007
- 2007-03-15 CY CY20071100363T patent/CY1106385T1/el unknown
-
2011
- 2011-03-01 US US13/037,989 patent/US20110152329A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20110152329A1 (en) | 2011-06-23 |
| DE60310975T2 (de) | 2007-07-12 |
| BR0315293A (pt) | 2005-08-30 |
| EP1553938A1 (en) | 2005-07-20 |
| DE60310975D1 (de) | 2007-02-15 |
| JP4672368B2 (ja) | 2011-04-20 |
| EP1553938B1 (en) | 2007-01-03 |
| WO2004035050A1 (en) | 2004-04-29 |
| CN1703217A (zh) | 2005-11-30 |
| DK1553938T3 (da) | 2007-03-26 |
| SI1553938T1 (sl) | 2007-06-30 |
| CY1106385T1 (el) | 2011-10-12 |
| ES2279139T3 (es) | 2007-08-16 |
| CA2501717C (en) | 2012-09-18 |
| CN1297269C (zh) | 2007-01-31 |
| JP2006504751A (ja) | 2006-02-09 |
| ATE350034T1 (de) | 2007-01-15 |
| CA2501717A1 (en) | 2004-04-29 |
| US20060142354A1 (en) | 2006-06-29 |
| PT1553938E (pt) | 2007-03-30 |
| HK1080768A1 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| IL189694A0 (en) | Biphenyl derivatives and their use in treating hepatitis c | |
| WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
| MY138352A (en) | Benzothiazole derivatives | |
| WO2001078711A3 (en) | Pde-v inhibitors for treatment of parkinson's disease | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| WO2003080582A3 (de) | Fredericamycin-derivate | |
| TW200420549A (en) | Thiazole derivatives | |
| GB0225475D0 (en) | Therapeutic agents | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
| WO2006011631A3 (en) | Thiazole derivatives having vap-1 inhibitory activity | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| IN2005KO00312A (https=) | ||
| WO2004014906A3 (en) | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents | |
| EP1627635A3 (en) | Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection | |
| WO2004044174A3 (en) | Topoisomerase-targeting agents | |
| AU2003267751A1 (en) | Use of epothilone derivatives for the treatment of hyperparathyroidism | |
| NZ504124A (en) | Phenyl-alkyl-imidazoles and use in treating inflammatory disease | |
| AU2368802A (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| WO2003080624A3 (en) | Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases | |
| PT1183046E (pt) | Derivado de aminotetralina para a terapia de doencas cardiovasculares | |
| HK1080369A1 (zh) | 用於治疗多发性骨髓瘤的埃博霉素衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |